Simmunome AI Companies

Simmunome creates accurate, comprehensive in silico disease models using multi-omic data to determine the probability of success of a drug. Our clinical trial simulations allow you to de-risk your pipeline, getting you to market faster and reducing your R&D costs.


Headquarters: Montreal, Quebec, Canada
Last Funding Type: Pre-Seed
Last Funding Date: 2020
Employee Number: 1-10
Founded Date: 2016
Estimated Revenue: $US62.5 billion
Industry: BioTech & Health Care